Guardant Health
GH
#2433
Rank
S$8.05 B
Marketcap
$65.21
Share price
2.72%
Change (1 day)
102.21%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: S$8.05 Billion

As of January 2025 Guardant Health has a market cap of S$8.05 Billion. This makes Guardant Health the world's 2433th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025S$8.05 B57.61%
2024S$5.11 B17.89%
2023S$4.33 B16.09%
2022S$3.73 B-72.83%
2021S$13.74 B-19.36%
2020S$17.04 B72.3%
2019S$9.89 B124.64%
2018S$4.40 B

End of Day market cap according to different sources

On Jan 27th, 2025 the market cap of Guardant Health was reported to be:

S$7.84 Billion
by Nasdaq info icon info icon
S$7.84 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$29.98 B 272.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.38 B-58.01%๐Ÿ‡บ๐Ÿ‡ธ USA